Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Study of Etomidate Induction in Hysteroscopic Surgery

NCT05520645 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05520645
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05520645 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Study of Etomidate Induction in Hysteroscopic Surgery
Lead sponsor
Peking University Third Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 25, 2022
Completion date
December 30, 2023
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

etomidate induced dose, hysteroscopic surgery